MAPK3 and Parkinson disease: GAS exerts antioxidant effects by promoting Nrf2 nuclear translocation and activating the ERK1/2 pathway, thereby reducing Aβ-induced oxidative damage in neurons and alleviating dyskinesia in the PD model mice (Wang et al., 2014).